Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | 2026-08-07 | Dambkowski Carl | Chief Medical Officer | Sale | 5,500 | $134.17 | $738K | 168.5K | View | |
| 2026-07-08 | 2026-07-10 | HENDERSON MICHAEL THOMAS | Director & Chief Executive Officer | Sale | 20.0K | $133.63 | $2.67M | 996.0K | View | |
| 2026-07-01 | 2026-07-02 | Dambkowski Carl | Chief Medical Officer | Sale | 5,500 | $132.74 | $730K | 177.9K | View | |
| 2026-06-22 | 2026-06-24 | Dambkowski Carl | Chief Medical Officer | Sale | 26.4K | $132.60 | $3.50M | 179.2K | View | |
| 2026-06-22 | 2026-06-24 | HENDERSON MICHAEL THOMAS | Director & Chief Executive Officer | Sale | 80.0K | $132.54 | $10.60M | 1.02M | View |
Informational purposes only, not investment advice.
tormere.com/research/APGE · generated 2026-10-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-05 | Dambkowski Carl | S | 5,500 | $737,935 |
| 2026-07-08 | HENDERSON MICHAEL THOMAS | S | 20,000 | $3M |
| 2026-07-01 | Dambkowski Carl | S | 5,500 | $730,070 |
| 2026-06-22 | Dambkowski Carl | S | 26,400 | $4M |
| 2026-06-22 | HENDERSON MICHAEL THOMAS | S | 80,000 | $11M |
Tormere — informational purposes only, not investment advice.